[go: up one dir, main page]

MX2019004414A - Un nuevo metodo para producir hemihidrato de sulfato de calcio con propiedades unicas. - Google Patents

Un nuevo metodo para producir hemihidrato de sulfato de calcio con propiedades unicas.

Info

Publication number
MX2019004414A
MX2019004414A MX2019004414A MX2019004414A MX2019004414A MX 2019004414 A MX2019004414 A MX 2019004414A MX 2019004414 A MX2019004414 A MX 2019004414A MX 2019004414 A MX2019004414 A MX 2019004414A MX 2019004414 A MX2019004414 A MX 2019004414A
Authority
MX
Mexico
Prior art keywords
calcium sulphate
sulphate hemihydrate
new method
unique properties
producing calcium
Prior art date
Application number
MX2019004414A
Other languages
English (en)
Inventor
Gruden Stefan
Axén Niklas
Original Assignee
Lidds Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57178277&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2019004414(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lidds Ab filed Critical Lidds Ab
Publication of MX2019004414A publication Critical patent/MX2019004414A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00Compounds of calcium, strontium, or barium
    • C01F11/46Sulfates
    • C01F11/466Conversion of one form of calcium sulfate to another
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B11/00Calcium sulfate cements
    • C04B11/02Methods and apparatus for dehydrating gypsum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10General cosmetic use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Geology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Ceramic Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Structural Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a un nuevo método para producir un hemihidrato de sulfato de calcio con propiedades únicas para uso en aplicaciones terapéuticas en la industria cosmética o farmacéutica. El hemihidrato de sulfato de calcio es una sustancia inorgánica biocompatible y biodegradable y, por lo tanto, adecuada como vehículo en composiciones farmacéuticas, por ejemplo una composición de liberación controlada, que contiene al menos un ingrediente farmacéuticamente activo.
MX2019004414A 2016-10-17 2017-10-16 Un nuevo metodo para producir hemihidrato de sulfato de calcio con propiedades unicas. MX2019004414A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16194209 2016-10-17
PCT/EP2017/076325 WO2018073165A1 (en) 2016-10-17 2017-10-16 A new method for producing calcium sulphate hemihydrate with unique properties

Publications (1)

Publication Number Publication Date
MX2019004414A true MX2019004414A (es) 2019-09-02

Family

ID=57178277

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019004414A MX2019004414A (es) 2016-10-17 2017-10-16 Un nuevo metodo para producir hemihidrato de sulfato de calcio con propiedades unicas.

Country Status (20)

Country Link
US (2) US10351437B2 (es)
EP (2) EP3331826B1 (es)
JP (1) JP7088919B2 (es)
KR (1) KR102408805B1 (es)
CN (1) CN109843807B (es)
AU (1) AU2017344893B2 (es)
BR (1) BR112019007478B1 (es)
CA (1) CA3038699A1 (es)
DK (1) DK3331826T3 (es)
ES (1) ES2778109T3 (es)
HK (1) HK1253356B (es)
HU (1) HUE043269T2 (es)
IL (1) IL266008B (es)
MX (1) MX2019004414A (es)
PL (1) PL3331826T3 (es)
RU (1) RU2753343C2 (es)
SG (1) SG11201902825RA (es)
TR (1) TR201905353T4 (es)
WO (1) WO2018073165A1 (es)
ZA (1) ZA201902949B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3038699A1 (en) * 2016-10-17 2018-04-26 Lidds Ab Calcium sulphate hemihydrate production via controlled air flow
JPWO2023189062A1 (es) 2022-03-31 2023-10-05

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956456A (en) * 1971-12-17 1976-05-11 National Gypsum Company Gypsum calcination
DE3141746A1 (de) * 1981-10-21 1983-05-05 Börgardts-Sachsenstein GmbH, 3425 Walkenried Kosmetische zubereitung und verfahren zu ihrer herstellung
GB2205089B (en) * 1987-05-22 1991-03-13 Rhein Westfael Elect Werk Ag Process for production of calcium sulphate alpha-hemihydrate
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
DE19620117C1 (de) * 1996-05-18 1997-07-24 Corimed Kundenorientierte Medi Verfahren zur Herstellung eines calciumsulfathaltigen medizinischen Präparats und calciumsulfathaltiges medizinisches Präparat
WO2001015665A1 (en) * 1999-09-02 2001-03-08 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
JP2002249317A (ja) * 2001-02-20 2002-09-06 Noritake Co Ltd 半水石膏の製造方法
JP5216601B2 (ja) 2006-03-14 2013-06-19 リッズ エービー 生体吸収性の制御放出組成物
WO2008074137A1 (en) 2006-12-20 2008-06-26 The Nugyp Corp. Calcium sulfate hemihydrate treatment process
DE102007024188B3 (de) * 2007-05-24 2008-04-10 Grenzebach Bsh Gmbh Verfahren zur Herstellung von Alpha-Calciumsulfat-Halbhydrat aus Calciumsulfat-Dihydrat und zugehörige Vorrichtung
CN101691286B (zh) * 2009-10-12 2011-09-07 孙恩光 α型半水石膏蒸压釜及其生产方法
JP5894170B2 (ja) * 2010-10-19 2016-03-30 リン,ジン−フェイ,チャン 硬化硫酸カルシウム二水和物ブロックの調製方法とその使用方法
US8586074B2 (en) * 2011-02-08 2013-11-19 Orthogen, Llc Calcium sulfate composite particles including aggregated calcium sulfate nanoparticles and method of use for bone augmentation
IN2014DN08829A (es) * 2012-04-11 2015-05-22 Induce Biolog Inc
EP2662329A1 (en) * 2012-05-11 2013-11-13 Creachem SA Peroxygen release compositions and method for producing them
EP2894135A1 (en) * 2014-01-10 2015-07-15 Saint-Gobain Placo SAS Method of curing a gypsum calcination product
US9895354B2 (en) * 2014-04-04 2018-02-20 University Of Kentucky Research Foundation Bilayered calcium sulfate/calcium phosphate space-making composites with multiple drug delivery capabilities
CN104310830B (zh) * 2014-10-21 2017-06-06 金正大生态工程集团股份有限公司 一种用磷石膏生产β‑高纯石膏粉的方法
CA3038699A1 (en) * 2016-10-17 2018-04-26 Lidds Ab Calcium sulphate hemihydrate production via controlled air flow
CN107055586A (zh) * 2016-12-30 2017-08-18 宁夏东吴农化有限公司 一种硫酸钙的制备方法

Also Published As

Publication number Publication date
DK3331826T3 (da) 2019-05-27
US10351437B2 (en) 2019-07-16
CN109843807A (zh) 2019-06-04
RU2753343C2 (ru) 2021-08-13
HUE043269T2 (hu) 2019-08-28
CN109843807B (zh) 2021-12-14
HK1253356B (en) 2020-02-07
EP3331826A1 (en) 2018-06-13
SG11201902825RA (en) 2019-05-30
JP2019532006A (ja) 2019-11-07
AU2017344893A1 (en) 2019-05-02
CA3038699A1 (en) 2018-04-26
PL3331826T3 (pl) 2019-08-30
KR102408805B1 (ko) 2022-06-14
JP7088919B2 (ja) 2022-06-21
US10611646B2 (en) 2020-04-07
BR112019007478A2 (pt) 2019-07-16
AU2017344893B2 (en) 2021-09-09
EP3498675A1 (en) 2019-06-19
BR112019007478B1 (pt) 2023-10-03
HK1253356A1 (en) 2019-06-14
IL266008B (en) 2022-08-01
US20190119122A1 (en) 2019-04-25
RU2019112298A (ru) 2020-11-17
ZA201902949B (en) 2020-12-23
ES2778109T3 (es) 2020-08-07
IL266008A (en) 2019-06-30
US20190345038A1 (en) 2019-11-14
EP3331826B1 (en) 2019-02-27
TR201905353T4 (tr) 2019-05-21
RU2019112298A3 (es) 2020-12-22
KR20190089854A (ko) 2019-07-31
WO2018073165A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
EP4289910A3 (en) Methods and compositions for wound healing
WO2015050449A3 (en) Biobased membrane
PH12017502040A1 (en) Oral care composition comprising calcium silicate
EP4327880A3 (en) Solid state form of ribociclib succinate
MY196791A (en) New tetrahydropyrimidodiazepin and dihydropyridodiazepin compounds for treating pain and pain related conditions
WO2019073331A3 (en) Pharmaceutical compositions of apremilast
MY197464A (en) Aza-indazole compounds for use in tendon and/or ligament injuries
BR112015013539A2 (pt) composições de formação de cimento, cimentos monetita, implantes e métodos para a correção de defeitos de ossos
WO2018088694A3 (ko) 인위적으로 조작된 sc 기능 조절 시스템
AU2017261160A1 (en) Implant surfaces for pain control
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
PH12019500690A1 (en) Oral care composition
PL408608A1 (pl) Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania
EA201790382A1 (ru) Способы лечения периимплантита
BR112015006727A8 (pt) uso de uma composição farmacêutica
BR112017010111A2 (pt) espaçador ("spacer") cerâmico para a troca bilateral de implantes em ombro, joelho e quadril como um resultado de infecções
TR201004464A2 (tr) Kemik erimesi için formülasyon.
MX2019004414A (es) Un nuevo metodo para producir hemihidrato de sulfato de calcio con propiedades unicas.
MX2019010228A (es) Composición para liberación controlada de sustancias fisiológicamente activas y proceso para su preparación.
AU2017370226A1 (en) Pharmaceutical composition containing insulin-like growth factor-2 and use thereof
PH12018502339B1 (en) Oral care composition
MX2019010229A (es) Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion.
MX388736B (es) Tratamiento de rescate de nausea y vomito post operatorio.
WO2017064652A3 (en) Low dose oral dipyridamole compositions and uses thereof